India Hopes To Narrow Pharma Trade Imbalance With Growing Importer China
This article was originally published in PharmAsia News
Executive Summary
In a rare visit by an Indian pharmaceutical delegation to China, Indian Ambassador Su Jiesheng voiced India's hopes to narrow the country's pharmaceutical trade imbalances with China by deepening cooperation
|
In a rare visit by an Indian pharmaceutical delegation to China, Indian Ambassador Su Jiesheng voiced India's hopes to narrow the country's pharmaceutical trade imbalances with China by deepening cooperation. During the visit, Indian drug giant Mankind's director indicated that Indian drug makers would like to establish joint ventures with their Chinese counterparts. China's drug enterprises urged India to reduce its frequent anti-dumping complaints against pharmaceutical products from China for the sake of fair competition. India is currently China's biggest API export market, accounting for 14.39% of China's total API exports. The API exports largely consist of low-priced products. (Click Here For More - Chinese Language) "India Drug Firms Eagle Eye Chinese Drug Market Amid Surging India-China Trade" - consumer.fivip.com (3/30/2011) |